Gilead Sciences's total assets for Q1 2025 were $56.43B, a decrease of -4.34% from the previous quarter. GILD total liabilities were $37.36B for the fiscal quarter, a -6.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.